Almost zero net cash - look out below!, page-5

"If the trial is a rip roaring success, then they are still tight for cash and will still need financing unless the oncology assets are sold pretty damn soon.". If the trial is a rip-roaring success, they won't be tight for cash because they can simply invite Merck to buy in. Past experience suggests that Merck would be only too pleased to do that. Basically, BNO's fate hinges on the two BNC210 trials. But it has been like that for quite a long time. Why panic now, if it could be seen from the start that the only meaningful news was always going to be the trial results, and trials take time...